The Valley Desk

Publications from Johnson & Johnson, page 31

A filtered view. Show the full list.

Refine

817 publications · listings 721–744

Listings

  1. ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

    Real-World Assessment of All-Cause Hospital Readmissions among Pulmonary Embolism Patients Treated With Rivaroxaban Versus Apixaban

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  2. ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

    Effectiveness and Safety of Rivaroxaban Versus Warfarin in Venous Thromboembolism Patients with Comorbid Obstructive Sleep Apnea: A Retrospective Cohort Study

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  3. Clinical trial reportAntiviral therapy

    Pediatric darunavir/cobicistat fixed-dose combination tablet for dispersion: Bioequivalence versus separate agents in healthy participants and acceptability in children living with human immunodeficiency virus-1

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  4. ArticleTherapeutic advances in musculoskeletal disease

    Safety, tolerability, and efficacy of the PD-1 agonist antibody JNJ-67484703 in adults with active rheumatoid arthritis: results of a multicenter, double-blind, placebo-controlled, randomized, multiple-dose phase Ib study

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  5. ArticleBlood

    Prognostic biomarkers in MCL: insights from the SHINE trial on the impact of MCL35 score and TP53 mutation status

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  6. Clinical trial reportBlood

    Daratumumab-bortezomib-thalidomide-dexamethasone for newly diagnosed myeloma: CASSIOPEIA minimal residual disease results

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  7. Clinical trial reportBlood

    Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  8. ArticleBlood

    Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma models

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  9. Clinical trial reportBlood

    Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  10. ArticleBlood advances

    Real-world survival outcomes in first-line ibrutinib-treated patients with high-risk CLL/SLL

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  11. Clinical trial reportBlood advances

    Infections and parameters of humoral immunity with talquetamab in relapsed/refractory multiple myeloma in MonumenTAL-1

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  12. ArticleBlood advances

    Long-term remission after cilta-cel in multiple myeloma is linked to diverse T cells and low myeloid suppression

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  13. ArticleBMC infectious diseases

    A qualitative burden of disease study in patients with invasive Escherichia coli disease aged ≥ 60 years in the United States

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  14. ArticleBMC psychiatry

    Clinical burden of major depressive disorder with versus without prominent anhedonia using a real-world electronic health records and claims linked database

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  15. ArticleBMC health services research

    Economic outcomes of diabetes self-management education among older Medicare beneficiaries with diabetes

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  16. ArticleTrials

    Guselkumab versus golimumab in patients with active psoriatic arthritis and inadequate response to an initial tumor necrosis factor inhibitor: study protocol for EVOLUTION, a pragmatic, phase 3b, open-label, randomized, controlled effectiveness trial

    Verified Author affiliations on the Europe PMC record name Drexel University College of Medicine, Johnson & Johnson, Perelman School of Medicine, with Drexel University, University of Pennsylvania linked by the institution reference. Affiliation source

    Clinical careAdded

  17. ArticleJournal of patient-reported outcomes

    Content validity and meaningful change for the FACIT-Fatigue scale in warm autoimmune hemolytic anemia: results from qualitative interview studies with patients

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Research dataAdded

  18. ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology

    Amivantamab Plus Lazertinib in Atypical EGFR-Mutated Advanced Non-Small Cell Lung Cancer: Results From CHRYSALIS-2

    Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source

    Disease researchAdded

  19. Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical Oncology

    Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  20. ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology

    Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma

    Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source

    Clinical careAdded

  21. Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical Oncology

    TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  22. ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology

    Gemcitabine Intravesical System Plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: SunRISe-4 Primary Analysis and Biomarker Results

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  23. ArticleJCO oncology practice

    Prostate Cancer Foundation White Paper on Combination Therapy for Metastatic Hormone-Sensitive Prostate Cancer

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  24. ArticleThe AAPS journal

    Best Practices and Recommendations for Non-Liquid Matrices Bioanalysis

    Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Merck & Co. Affiliation source

    Biomedical and life sciencesAdded